Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency
The DOI matches its Crossref record; 18 of the 19 references it cites were found in a registry or an index.
Abstract
Prednisolone has unknown growth-suppressing effects relative to other steroids. We retrospectively studied 9 children (6 with congenital adrenal hyperplasia, CAH) receiving hydrocortisone replacement after switching to prednisolone (dose ratio, 1:5). Growth velocity and, in patients with CAH, 17-OHP decreased significantly. Dose reduction reversed these effects. Roughly, growth suppression relative potency for prednisolone:hydrocortisone was 15:1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In one trial, the estimated growth-suppressive effect of prednisolone was ;15-fold more potent than that of HC (188); Dex may be up to 70-to 80-fold more potent than HC (189).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [188]
Citations
Cites
Clinical longitudinal standards for height and height velocity for North American children
Tanner, J. M., & Davies, P. S. W. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80501-1 · Cited by 1,092
Potency and duration of action of glucocorticoids
Meikle, A. W., & Tyler, F. H. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90233-9 · Cited by 319
Berne, C., Gunnarsson, R., Hellerström, C., & Wilander, E. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92474-x · Cited by 175
Reference data on gains in weight and length during the first two years of life
Guo, S. S., Roche, A. F., Fomon, S. J., Nelson, S. E., Chumlea, W. C., Rogers, R. R., Baumgartner, R., Ziegler, E. E., & Siervogel, R. M. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82045-1 · Cited by 132
CONGENITAL ADRENAL HYPERPLASIA OWING TO 21-HYDROXYLASE DEFICIENCY
Speiser, P. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70018-5 · Cited by 109
Resampling: A Tool for Everyday Statistical Work
Simon, J. L., & Bruce, P. C. (1991) · CHANCE · doi:10.1080/09332480.1991.11882408 · Cited by 99
Congenital Adrenal Hyperplasia
Handwerger, S., & Silverstein, J. H. (1977) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)01038-7 · Cited by 70
Metre, T. E. V., Niermann, W. A., & Rosen, L. J. (1960) · Journal of Allergy · doi:10.1016/0021-8707(60)90088-5 · Cited by 65
Congenital Adrenal Hyperplasia
Doneva, V., Sadikario, A., Zdraveva, M., Vlaški, J., & Grozdanov, L. (2017) · American Academy of Pediatrics eBooks · doi:10.1542/9781610020862-part02-congenital · Cited by 52
CLINICAL AND METABOLIC EFFECTS OF DEXAMETHASONE
Slater, J. D. (1959) · The Lancet · doi:10.1016/s0140-6736(59)90370-8 · Cited by 39
Research works printed but not linked: 2
- Falliers, 1963, Childhood asthma and steroid therapy has influences on growth, Am J Dis Child, 105, 41
- Boland, 1952, Hydrocortisone (Kendall's Compound F): experiences with the free and acetate forms in rheumatoid arthritis, J Am Pharm Assoc, 13, 540
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
“nisolone was about 15-fold more potent than HC (119);”
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
PW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Metadata
- Authors
- Punthakee, Z., Legault, L., & Polychronakos, C.
- Affiliations
- Montreal Children's Hospital (CA)
- Corresponding author
- Polychronakos, Constantin
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 2003-09
- Volume
- 143
- Issue
- 3
- Pages
- 402-405
- ISSN
- 0022-3476 (ISSN-L)
- OpenAlex
- W2115411931
- Cited by
- 95
- References
- 19
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 2 · 2019: 6 · 2018: 8 · 2017: 1 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 3 · 2012: 3
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Journal of Pediatrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- prednisolone, adrenal insufficiency, congenital adrenal hyperplasia, hydrocortisone replacement, growth inhibition, relative potency, 17-hydroxyprogesterone, dose reduction, children
- MeSH terms
- Adrenal Insufficiency, Adrenal Hyperplasia, Congenital, Anti-Inflammatory Agents, Child, Child, Preschool, Dose-Response Relationship, Drug, Female, Growth Disorders, Humans, Hydrocortisone, Infant, Male, Prednisolone, Retrospective Studies, Therapeutic Equivalency, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency. https://app.cochat.ai/papers/10.1067/s0022-3476(03)00294-4
- The paper
- Punthakee, Z., Legault, L., & Polychronakos, C. (2003). Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency. The Journal of Pediatrics. https://doi.org/10.1067/s0022-3476(03)00294-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.